Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or oth
Financial Statements and Exhibits. (d) Exhibits Exhibit No . Description 99.1 Press Release issued by Tango Therapeutics, Inc. on March 5, 2026 relating to its